Joint Health Benefits of CM Complex (with Cetylmyristoleate)

We get calls periodically from our wonderful Doctor-Distributors asking technical questions about ArthroAid Plus, and periodically I like to address them for our large group of Doctor’s/Patients. Today’s question: “I understand the benefits of most of the ingredients in ArthroAid Plus, but what exactly is the CM Complex and it’s benefit?”

Great question. The CM stands for cetyl myristoleate, the complex is made up of cetylated esters of fatty acids derived from bovine tallow. The complex was discovered by Harry W. Diehl in 1964 a research chemist while working for The National Institute of Arthritis, Metabolic, and Digestive Diseases in Bethesda, MD. Mr. Diehl studied the seeming immunity of mice to arthritis, and discovered cetyl myristoleate through his research, investigations, testing and analysis.

Diehl’s research was published in the March 1994 issue of the American Journal of Pharmaceutical Sciences, the Journal of the American Pharmaceutical Association and The American Chemical Society. Mr. Diehl received three “use ” patents on cetyl myristoleate. After receiving his first patent Mr. Diehl immediately approached the pharmaceutical industry, including Pfizer and Merck, with his discovery but they declined. This mainly due to rules concerning “product” patents on natural products, eliminating exclusivity rights. Mr. Diehl’s daughter finally brought the product to market in the mid-1990’s. This is our source for CM Complex.

This CM Complex has multiple biological properties, and has shown in human studies to act as an anti-inflammatory and a pain-reliever, as well as a possible immuno-modulator (effecting RA) see www.nutraresearch.net for study links*. Because it is an ester form, highly resistant to oxidation, it has a relativiely long life in the body. No harmful short or long-term effects have ever been observed in humans or animals.

Nutra Research has been involved for over 15 years with the ingredient and began providing it for human clinical trials overseas. As recently as 2009 the KFDA (Korean Food & Drug Administration) approved this ingredient for distribution through pharmacies as a treatment for joint pain. We currently have an exclusive agreement to provide this ingredient in South Korea.

We appreciate inquiries and a chance to instill confidence in our products. Please visit our web site and take advantage of the resources we provide there. Questions or comments? Join the conversation at www.facebook.com/nutraresearch or follow me on Twitter @arthroaidplus.